Next Biomedical Co.,Ltd. (KOSDAQ:389650)

Next Biomedical Statistics

Total Valuation

Next Biomedical has a market cap or net worth of KRW 516.06 billion. The enterprise value is 496.26 billion.

Market Cap	516.06B
Enterprise Value	496.26B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Next Biomedical has 8.13 million shares outstanding. The number of shares has increased by 29.11% in one year.

Current Share Class	8.13M
Shares Outstanding	8.13M
Shares Change (YoY)	+29.11%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	32.05%
Owned by Institutions (%)	7.58%
Float	5.04M

Valuation Ratios

The trailing PE ratio is 200.46.

PE Ratio	200.46
Forward PE	n/a
PS Ratio	42.43
PB Ratio	11.48
P/TBV Ratio	11.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	192.77
EV / Sales	40.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-111.96

Financial Position

The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.26.

Current Ratio	3.07
Quick Ratio	2.81
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-2.60
Interest Coverage	-5.81

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-5.84%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +93.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+93.60%
50-Day Moving Average	51,628.00
200-Day Moving Average	45,265.50
Relative Strength Index (RSI)	70.50
Average Volume (20 Days)	98,928

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Next Biomedical had revenue of KRW 12.16 billion and earned 2.57 billion in profits.

Revenue	12.16B
Gross Profit	7.88B
Operating Income	-2.77B
Pretax Income	2.57B
Net Income	2.57B
EBITDA	-2.27B
EBIT	-2.77B
Earnings Per Share (EPS)	-272.78

Balance Sheet

The company has 31.35 billion in cash and 11.55 billion in debt, giving a net cash position of 19.80 billion or 2,436.27 per share.

Cash & Cash Equivalents	31.35B
Total Debt	11.55B
Net Cash	19.80B
Net Cash Per Share	2,436.27
Equity (Book Value)	44.96B
Book Value Per Share	5,532.48
Working Capital	24.87B

Cash Flow

In the last 12 months, operating cash flow was -1.82 billion and capital expenditures -2.61 billion, giving a free cash flow of -4.43 billion.

Operating Cash Flow	-1.82B
Capital Expenditures	-2.61B
Free Cash Flow	-4.43B
FCF Per Share	-545.43

Margins

Gross margin is 64.75%, with operating and profit margins of -22.77% and 21.16%.

Gross Margin	64.75%
Operating Margin	-22.77%
Pretax Margin	21.16%
Profit Margin	21.16%
EBITDA Margin	-18.64%
EBIT Margin	-22.77%
FCF Margin	n/a

Dividends & Yields

Next Biomedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.11%
Shareholder Yield	n/a
Earnings Yield	0.50%
FCF Yield	-0.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Next Biomedical has an Altman Z-Score of 12.86 and a Piotroski F-Score of 3.

Altman Z-Score	12.86
Piotroski F-Score	3